摘要 |
The present invention relates to an indazole derivative, pharmaceutically acceptable salt, solvated product and isomer thereof substituted with 1,1-dioxoisothiazolidine which are useful as inhibitors for Cyclin Dependent Kinase(CDK). The present invention also relates to an agent for inhibiting and treating diseases involving cell proliferation, e.g., cancer, inflammation, restenosis, angiogenesis, etc. which comprises the indazole derivative as an active ingredient together with a pharmaceutically acceptable carrier. |
申请人 |
LG CHEM INVESTMENT LTD.;LEE, JIN, HO;HONG, CHANG, YONG;PARK, TAE, SIK;KIM, JONG, HYUN;CHOI, SEI, HYUN;YOON, SOOK, KYUNG;CHUNG, HYUN, HO;JEONG, SHIN, WU;HWANG, KWANG, YEON;SHIN, DONG, KYU |
发明人 |
LEE, JIN, HO;HONG, CHANG, YONG;PARK, TAE, SIK;KIM, JONG, HYUN;CHOI, SEI, HYUN;YOON, SOOK, KYUNG;CHUNG, HYUN, HO;JEONG, SHIN, WU;HWANG, KWANG, YEON;SHIN, DONG, KYU |